About Proxim Diagnostics
Proxim Diagnostics is a company based in Sunnyvale (United States) founded in 2010. Proxim Diagnostics has raised $22.9 million across 5 funding rounds from investors including BioMerieux. Proxim Diagnostics offers products and services including Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test. Proxim Diagnostics operates in a competitive market with competitors including GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Proxim Diagnostics Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$22.9 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proxim Diagnostics
Proxim Diagnostics offers a comprehensive portfolio of products and services, including Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test.
Portable device for accurate immunodiagnostic testing using whole blood.
Low-cost cartridges designed for various diagnostic tests.
Quantitative blood test for detecting pregnancy levels.
Blood test to identify sepsis markers in patients.
People of Proxim Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Proxim Diagnostics
Proxim Diagnostics has successfully raised a total of $22.9M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Proxim Diagnostics
Proxim Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BioMerieux.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of diagnostics devices for multiple health purposes
|
Locked | Locked | Locked |
Investor details for Proxim Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Proxim Diagnostics
Investment portfolio details for Proxim Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Proxim Diagnostics
Detailed financials for Proxim Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Proxim Diagnostics Comparisons
Peer comparison for Proxim Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Proxim Diagnostics
Proxim Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetic and clinical data are integrated for precision cardiac medicines.
|
|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Interventional cardiology devices are developed and marketed globally.
|
|
| Locked | Locked | Locked |
Cardiac imaging systems are manufactured using advanced molecular technologies.
|
Detailed competitors of Proxim Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Proxim Diagnostics
Complete news archive for Proxim Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proxim Diagnostics
Proxim Diagnostics was founded in 2010.
Proxim Diagnostics is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Proxim Diagnostics is a funded company, having raised a total of $22.9M across 5 funding rounds to date.
Proxim Diagnostics was founded in 2010 and is based in Sunnyvale, United States. Operations focus on the medical diagnostics sector, where a handheld immunodiagnostic device is developed for detecting cardiac vascular diseases. Capabilities include testing for cardiac markers, blood gases, electrolytes, metabolites, as well as infectious disease antigens and antibodies. The device supports point-of-care applications in healthcare settings.
Proxim Diagnostics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
Proxim Diagnostics offers Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test.
Proxim Diagnostics has 1 investor. Key investors include BioMerieux.